• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.74% Nasdaq Up 0.92%

    Alimera Sciences, Inc. (ALIM)

    -NasdaqGM
    1.58 Sep 27, 3:59PM EDT
    Prev Close:1.58
    Open:N/A
    Bid:1.53 x 400
    Ask:1.64 x 4400
    1y Target Est:6.00
    Beta:2.10591
    Earnings Date:Nov 3 - Nov 7 (Est.)
    Day's Range:N/A - N/A
    52wk Range:1.01 - 5.15
    Volume:0
    Avg Vol (3m):905,433
    Market Cap:99.82M
    P/E (ttm):N/A
    EPS (ttm):-0.68
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALIM

    Comparison

    Symbol% ChgMkt Cap
    ALIM 0.00%99.82M
    AGN94.78B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.57
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.53
    Quarterly EPS Est (Sep-16) :-0.11
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alimera Sciences, Inc., a pharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals in the United States, Germany, Portugal, and the United Kingdom. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback